And if Alterity is aware of patient baseline data in the -201 trial, isn’t it possible they can say that patient is to be replaced on the trial, even though they may qualify, because they want someone who is more likely to respond positively if given the lower or higher dose?
And if Alterity is aware of patient baseline data in the -201...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $10.07K | 3.191M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 22568002 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127369917 | 27 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |